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ABSTRACT 
Objective: Surgical procedure and adjuvant treatment of type I endometrial cancer were affected by some variables assessed preoperatively. 
Diffusion-weighted magnetic resonance imaging (DWI) is a promising modality in evaluating myometrial invasion and cervical involvement, 
investigating the diagnostic values of DWI in assessing myometrial invasion and cervical involvement. 
Methods: A cross-sectional study was conducted. This study involved all type I endometrial cancer patients in Dr. Cipto Mangunkusumo Hospital 
from April 2016 until April 2019. The depth of myometrial invasion and cervical involvement was examined using 1.5-T MR unit. The result was 
compared to the surgical pathologic findings as the reference standard. 
Results: 34 types I endometrial cancer patients were enrolled in this study. The sensitivity of DWI in evaluating myometrial invasion and cervical 
involvement in type I endometrial cancer was 94.12% and 57.14%, while the specificity was 64.71% and 92.59%, respectively. 
Conclusion: DWI can provide reliable prognostic variable information about the myometrial invasion and cervical involvement in the preoperative 
preparation of endometrial cancer patients. 
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As the second most common of female genital organ cancer after cervical 
cancer, about 382,069 cases on 2018, endometrial cancer is very crucial 
to be managed [1]. The most common type of endometrial cancer is type 
I endometrial cancer, which is an estrogen-dependent carcinoma 
characterized with endometrioid adenocarcinoma in histopathology 
examination. The main treatment for endometrial cancer is surgery. 
Surgical procedure and adjuvant treatment of type I endometrial cancer 
were affected by some variables assessed preoperatively. Stage, 
myometrial invasion, grade histology, LVSI status, tumor size are 
important variables that may be assessed preoperatively.  
Magnetic resonance imaging (MRI) has shown its superiority in 
evaluating endometrial cancer cases. Diffusion-weighted magnetic 
resonance imaging (DWI) is a functional imaging technique that 
displays information about water mobility, tissue cellularity, and 
integrity of the cellular membranes. Endometrial tumors exhibit 
restricted diffusion compared with surrounding tissue, 
demonstrated as the high signal intensity at DWI [2]. DWI offers 
promising preoperative examination in evaluating endometrial 
cancer. This study will be focused to evaluate the diagnostic capacity 
of magnetic resonance diffusion imaging in predicting myometrial 
invasion and cervical involvement of type I endometrial cancer.  
 
Table 1: Characteristic of patients with type I endometrial cancer 
Characteristic Patients % 










BMI   
 Underweight (<18.5) 
Normal (18.5-22.9) 
Overweight (23-24.9) 
Obesity I (25-29.9) 


















Diabetes Mellitus   
















Myometrial invasion and cervical involvement were evaluated preoperatively using DWI. Histopathology examination was done postoperatively as 
a gold standard. The result was shown in table 2-5. 
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MATERIALS AND METHODS 
This study compared DWI assessment in predicting myometrial 
invasion and cervical involvement in type I endometrial cancer to 
the postoperative histopathology results. We included all type I 
endometrial carcinoma patients in Dr. Cipto Mangunkusumo General 
Hospital from April 2016 to April 2019 with available preoperative 
DWI. Data were collected from medical records. Institutional review 
board approval was obtained in this retrospective study.  
DWI examination was performed using 1.5-T MRI scanner. Imaging 
data were retrieved from the picture archiving and communication 
system (PACS) and reviewed by the experts. Histopathology analysis 
was done by section along the longitudinal plane of the uterus. 
Assessment was estimated grossly and confirmed microscopically 
without knowledge of the MR findings. Myometrial invasion and 
cervical involvement were evaluated in this study. Myometrial 
invasion was categorized into two levels: 1) invasion less than 50% 
of the myometrial thickness (including tumor confined to the 
endometrium only), 2) invasion 50% or more of myometrial 
thickness. Cervical involvement was categorized as tumor invasion 
of cervical stroma and no tumor invasion of the cervical stroma.  
RESULTS 
A total of 67 endometrial cancer patients had surgery in our hospital. 
Histology result of type I endometrial cancer was found in 50 
patients with 34 preoperative DWI available. Patients’ age ranged 
from 22 to 73 y old, with a median of 55 y old. Characteristics of 
patients are shown in table 1. 
 
Table 2: DWI myometrial invasion findings compared to the histopathology examination 
 Histopathology Total 
≥  50% invasion < 50% invasion 
MR-DWI ≥  50% invasion 16 6 22 
< 50% invasion 1 11 12 
 Total 17 17 34 
 
Table 3: Diagnostic values of DWI compared to the gold standard 
Parameter Estimate Lower-upper 95% CI 
Sensitivity 94.12% (73.02–98.95) 
Specificity 64.71% (41.3–82.69) 
Positive predictive value 72,.73% (51.85-86.85) 
Negative predictive value 91.67% (64.61–98.51) 
Accuracy 79.41% (63.2-89.65) 
Positive likelihood ratio 2.667 (1.909–3.725) 
Negative likelihood ratio 0.09091 (0.01162–0.7113) 
 
Table 4: DWI findings in evaluating cervical involvement compared to the histopathology examination 
 Histopathology Total 
Yes No 
MR-DWI Yes 4 2 6 
No 3 25 28 
Total 7 27 34 
 
Table 5: Diagnostic values of MR-DWI compared to histological findings in assessing cervical involvement 
Parameter Estimate Lower-Upper 95% CI 
Sensitivity 57.14% (25.05–84.18) 
Specificity 92.59% (76.63–97.94) 
Positive predictive value 66.67% (30.0-90.32) 
Negative predictive value 89.29% (72.8-96.29) 
Accuracy 85.29% (69.87–93.55) 
Positive likelihood ratio 7.714 (2.005–29.68) 
Negative likelihood ratio 0.4629 (0.2393–0.8952) 
 
DISCUSSION 
In our study, we have observed the characteristic of the endometrial 
carcinoma patient in Dr. Cipto Mangunkusumo General Hospital. 
More than half of type I endometrial carcinoma patients in our 
hospital were nulliparous women. Overweight and obesity were 
found in the majority of patients. These results corresponded with 
the previous meta-analysis in 2018, which revealed that endometrial 
carcinoma had a strong association with these factors. Parity 
reduced risk of disease (RR 0.66; 95%CI 0.60-0.74). Body mass index 
was strongly associated with increased overall cancer risk in 
premenopausal women (RR per 5 kg/m2 1.49; 95%CI 1.39-1.61), 
while the waist-to-hip ratio was associated with total endometrial 
cancer (RR per 0.1 unit 1.21; 95%CI 1.13-1.29) [3]. Despite the slow 
progression in type I endometrial cancer, most of our patients were 
diagnosed with low-grade endometrial cancer. This condition might 
be caused by the patient’s tendency to go to the doctor immediately 
when there was vaginal bleeding.  
Sensitivity of DWI in assessing myometrial invasion in this study 
was good. It showed that DWI was good in identifying patients with 
deep myometrial invasion. Specificity of DWI in assessing 
myometrial invasion was moderate. It correlates with low positive 
predictive value. These values may lead to overtreatment in some 
low-risk endometrial cancer patients. However, it is clinically 
acceptable due to the difference in management guidelines. NCCN 
recommends surgical staging in almost all endometrial cancer, 
except patients with low risk for nodal metastases (less than 50% 
myometrial invasion, tumor less than 2 cm, well or moderately 
differentiated histology). Sentinel lymph node mapping may be 
considered in selected patients [4]. Lymphadenectomy is not 
recommended by ESGO in low-risk endometrial cancer and only 
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considered in intermediate risk endometrial cancer. Data has not 
shown survival benefit but may be considered for staging purpose 
[5]. Adjuvant treatment is affected by prior surgery management. 
Incomplete surgical procedure will cause additional adjuvant 
treatment. Risk and complication of surgical staging is more 
tolerable than adjuvant treatment. 
Six patients were identified having deep myometrial invasion with 
DWI, whereas the histopathology result was a superficial 
myometrial invasion. This result might contribute to the low 
specificity and positive predictive value of DWI in evaluating 
myometrial invasion. Four out of six patients had other pathological 
conditions besides endometrial cancer. Adenomyosis, leiomyoma, 
and other pathological condition may affect the interpretation of 
DWI. This pitfall has been identified in the Guideline of The 
European Society of Urogenital Radiology 2019 [6]. Large tumor 
size, thin myometrium, uterine atrophy, isointense endometrial 
tumor, uterine body involvement, and other anatomical distortion 
may interfere with the interpretation. 
DWI is usually performed after the diagnosis of endometrial cancer 
established. Diagnosis of endometrial cancer should be based on 
histopathology result. Therefore, endometrial sampling usually 
performed prior DWI. Bleeding and inflammation in the uterine 
cavity may lead to misinterpretation in DWI. However, more than 
one-week time interval will mostly diminish misinterpretation in 
evaluation myometrial invasion. The data about the time interval 
between endometrial sampling and DWI examination was not 
available in this study. This limitation should be considered when 
interpreting the results.  
Apparent diffusion coefficient as a quantitative analysis may 
improve the result in evaluating the myometrial invasion of 
endometrial cancer. Endometrial cancer tends to show a lower 
apparent diffusion coefficient compared to normal tissue or benign 
lesion. This study was using ADC value cutoff 1 x 10-3 mm2/s. In the 
study of Takeuchi et al., the mean ADC value was 0.84±0.19 x 10-3 
mm2/s and 1.58±0.36 x 10-3 mm2/s for endometrial cancer and 
normal tissue, respectively. Using ADC value cutoff 1.2 x 10-3 mm2/s 
will result sensitivity 96% and specificity 95% [7]. Meta-analysis 
study in 2019 showed the result of sensitivity, specificity, and area 
under the curve of ADC to evaluate myometrial invasion were 71%, 
67%, and 77%, respectively. It should be noticed that the ADC value 
cutoff in this meta-analysis varied from 0.75 to 0.77 [8]. The ideal 
ADC value cutoff was still disputable.  
There was a limited reference of cervical involvement evaluation 
using DWI. In this study, there is a disproportion and lack of 
sample size in the cervical involvement of endometrial cancer 
patients. Only seven patients (20.5%) were positive for cervical 
involvement among 34 patients in this study. Sensitivity of DWI in 
evaluating cervical involvement was 57.14% (CI 25.05-84.18). 
Wide confidence interval corresponds to the small number of 
sample. Though, there was a study in 2016 showed similar 
sensitivity in the evaluation of cervical involvement using dynamic 
contrast-enhanced (58.3% and 50%) [9]. High specificity result of 
cervical involvement evaluation in this study showed that DWI is 
able to exclude cervical involvement in endometrial cancer. 
Misinterpretation in cervical involvement may be caused by 
several factors such as: the extreme angle between uterus and 
cervix, minimal slices in DWI. Despite of these results, there is no 
difference on hysterectomy procedure type related to cervical 
involvement (except for parametrium involvement). Low 
sensitivity of DWI can also be tolerated due to the rarity of cervical 
involvement in low-risk endometrial cancer or superficial 
myometrial invasion. 
We recognize that there are some limitations in this study. Even 
though we have included all of endometrial cancer in our institution, 
only a few were included due to the limited number of patients. 
Further study with a larger sample should be performed to improve 
the result. Second, the variability of the time interval between DWI 
and surgery procedure may affect the disease progression, which 
may interfere the interpretation. The last limitation was we only 
used single-axis image analysis due to the limited resources. It 
should be considered to use a multiple slice and axis to avoid 
misinterpretation. Quantitative evaluation in DWI using apparent 
diffusion coefficient may improve the result. 
CONCLUSION 
This study demonstrated the usefulness of magnetic resonance 
diffusion imaging in evaluating myometrial invasion and cervical 
involvement for type I endometrial cancer. Some factors were 
recognized in misinterpretation of diffusion-weighted imaging, such 
as: cornual involvement, tumor size, uterine atrophy, anatomical 
factors, and multislice imaging. Those factors should be noticed to 
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